Immunological aspects of immunodeficiency diseases part 36

Immune 3

 

TREATMENT OF ANTIBODY DEFICIENCY

Prospective clinical studies have shown that optimal IgG replacement therapy reduces the incidence of sepsis and complications like structural lung damage. If replacement therapy is introduced early before organ damage is established, antibody-deficient individuals are likely to have a normal life span. Replacement immunoglobulin is prepared from plasma pooled from large cohorts of normal donors. Current practice of prescreening donors for infection and multiple antiviral steps employed during the manufacture of plasma have eliminated the risk of HIV and hepatitis B and C transmission. Different immunoglobulin products are licensed for administration via the intravenous or subcutaneous route.

Advertisements

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s